Famar, a contract development and manufacturing organization serving the pharmaceutical and health and beauty segments, has agreed to acquire Roche’s manufacturing site in Leganes, Spain. With the agreement, the companies have also signed a long-term manufacturing agreement that will allow Famar Leganes to supply Roche in the future from this facility with the current portfolio of products produced at the site.The transfer of full ownership of the Leganes site is expected to be completed July 1, 2016.

Famar has an existing network of 11 manufacturing sites in Europe with facilities in Spain, Italy, Greece, France, and the Netherlands. The Leganes site provides Famar with capacities and expertise in the production of solid dosage forms with high-potency active pharmaceutical ingredients, which represents new technology for the company and adds to Famar’s technology portfolio in solid dosage formulations.

Earlier this year, Famar agreed to acquire the manufacturing site in Pointe-Claire, Quebec from the Consumer Health Division of Bayer with the deal expected to close in early 2017. The acquisitions of the Quebec and Leganes sites will provide Famar with two FDA-approved sites in its global manufacturing network.

Source: Famar